[乳腺癌中的HER-2/neu检测：免疫细胞化学是否胜任？]
[HER-2/neu-testing in breast cancer: is the immunocytochemistry competent?].
作者信息
Matsionis A É, Pavlenko I A, Petrov A V, Povilaĭtite P E
出版信息
Arkh Patol. 2012 Mar-Apr;74(2):42-5.
PMID:22880415
Abstract
According to ASCO/CAP guidelines, there are two recommended methods for Her2/neu-testing in breast cancer patients such as immunohistochemistry and fluorescence in situ hybridization. This paper analyses results of alternative immunocytochemical method for Her2/neu detection and its diagnostic pitfalls.
摘要
根据美国临床肿瘤学会/美国病理学家协会（ASCO/CAP）指南，对于乳腺癌患者，有两种推荐的Her2/neu检测方法，如免疫组织化学和荧光原位杂交。本文分析了用于Her2/neu检测的替代免疫细胞化学方法的结果及其诊断陷阱。
Zotero 插件